JAK2 V617F Mutation Detection(EX0N 14)
ITEM ID
N249
Item Name
JAK2 V617F ALLELIC RATIO
DOCTOR SPECIALITY
Hematologist, Oncologist , Nephrologist, Hepatologist
DISEASE DESCRIPTION
Cancer
Test Status
Active
N249 JAK2 V617F ALLELIC RATIO
Specimen
3 mL (2 mL min.) Whole blood in 1 Lavender Top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Physician Prescription is mandatory.
Method:
Droplet digital PCR
Report:
Sample submitted by 2nd day of the month. Report issued in 4 weeks.
Usage:
The JAK2 mutation can be detected in 65-97% of Polycythemia vera, 25-55% of Essential thrombocythemia, and 35-57% of Chronic idiopathic myelofibrosis. This test detects the V617F mutation for JAK2. This assay aids in the distinction between Reactive cytosis & Chronic myeloproliferative disorder. This test also gives the allelic ratio for this mutation.
Doctor Specialty:
Hematologist, Oncologist , Nephrologist, Hepatologist
Disease:
Cancer
Components::
*JAK2 V617F ratio
Department:
MOLECULAR DIAGNOSTICS
Pre Test Information:
Physician Prescription is mandatory.